Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-318100

Director acquired 8,789 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vieser Jaime Director 2026-07-23 Grant or award +8,789 $1.92 $16,875 47,642 D: show line 1 in the form
Loading xslF345X06/ownership.xml…